当前位置: 首页 > 期刊 > 《医学信息》 > 20149
编号:13694988
FENO在COPD患者急性加重期及缓解期中相关关系的研究(2)
http://www.100md.com 2014年3月5日 符丹丹 欧阳瑶
第1页

    参见附件。

     参考文献:

    [1]Kharitonov SA, Donnel1y LE, Montusch iP, et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma[J].Thorax,2002,57:889-896.

    [2]Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for the Diagnosis,Management,and Prevention of Chronic Obstructive Lung Disease[EB/OL],2006.

    [3]Silkoff PE.ATS/ERS Recommendations for standardized procedures for the online measurement of exhaled low er respiratory nitric oxide and nasal nitric oxide,2005[J]. Am J Respir Crit Care Med,2005,171(8):912-930.

    [4]Migneauh A, Sauvageau S. Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide[J].Am J Respir Crit Care Med.2005,171(5):506-513

    [5]Katsuyama K, Shiehiri M, Kato H, et al. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells[J].Endocrinology,1999,140:2183-2190.

    [6]Kharitonov SA, Bames PJ. Clinical aspects of exhaled nitric oxide[J].Eur Respir J,2000,16:781-792.

    编辑/肖慧

    

您现在查看是摘要介绍页,详见PDF附件